Pfeiffer Vacuum apprentices win award for virtual training film
Avoids translation misunderstandings as pumps firm expands into Asia
Alena Bölzer, Meike König, Oxana Pozdeev and Lisa Weichl won the ‘Unique products and services’ category for their virtual training films, which explain the steps involved in handling individual turbo pumps and other Pfeiffer Vacuum products. The films are practically speech-free so that any misunderstandings in language translation are avoided.
‘We are proud of our young employees,’ said Matthias Wierner, executive board member responsible for marketing, production and development at Pfeiffer Vacuum Technology. ‘They have not only had a great idea and implemented it well but have also presented their results professionally. Pfeiffer Vacuum will this year become even more international with a clear orientation towards Asia. We are very pleased that this situation is being addressed constructively and innovatively by all our staff.’
The company recently set up a subsidiary in São Paulo, Brazil and now has its own subsidiaries in Brazil, Russia, India and China.
Pfeiffer Vacuum reported unaudited sales of €220.5m in 2010, an increase of 21%.
You may also like
Manufacturing
Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies
Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Finance
Moderna partners with Recordati to commercialise propionic acidemia mRNA therapy
The pair have entered a strategic collaboration to advance and globally commercialise its investigational propionic acidemia treatment mRNA-3927, with Moderna leading clinical development and manufacturing and Recordati responsible for worldwide commercialisation
Finance
AstraZeneca strengthens weight management pipeline with CSPC Pharmaceuticals collaboration
The pair have signed a strategic collaboration covering eight obesity and type 2 diabetes programmes, including a clinical-ready GLP-1/GIP asset, AI-driven peptide discovery capabilities and injectable dosing technology